相关实验视频

Updated: Jul 12, 2025

Development of an In Vitro Ocular Platform to Test Contact Lenses

Development of an In Vitro Ocular Platform to Test Contact Lenses

Published on: April 6, 2016

患者对治疗性隐形眼镜和干眼疾病的经验

Ellen Shorter¹, Cherie B Nau, Jennifer S Fogt

¹University of Illinois at Chicago (E.S.), Chicago, IL; Mayo Clinic (C.B.N., M.S.), Rochester, MN; The Ohio State University (J.S.F.), Columbus, OH; Korb and Associates (A.N.), Boston, MA; andIllinois College of Optometry (J.H.), Chicago, IL.

Eye & contact lens

|November 1, 2023

概括

患者使用治疗性隐形眼镜干眼疾病经常经历中午视力雾化. 膜透镜佩戴者报告每天的时间投入和每年的干眼管理支出最高.

科学领域:

眼科医生眼科眼科
视光学测量视光学测量视光学测量
生物医学工程生物医学工程

背景情况:

干眼病 (DED) 显著影响患者的生活质量.
治疗性隐形眼镜,包括软眼镜和硬眼镜 (SL),用于管理DED.
了解患者对这些镜片的体验对于优化护理至关重要.

研究的目的:

调查和报告患者报告的DED.体验.
为了比较非透镜佩戴者,软疗法透镜佩戴者和硬膜透镜佩戴者之间的经验.

主要方法:

对639名被诊断患有DED的患者进行了一项调查.
收集的数据包括人口统计,眼部表面疾病指数 (OSDI) 评分,全身疾病和隐形眼镜史.
根据镜头佩戴状况对答案进行了分类:非镜头,软镜头和硬膜镜头.

主要成果:

15%的受访者 (94/639) 使用治疗性软或膜透镜.
中午视力障碍 (雾/模糊) 很常见:SL佩戴者中有75%,软透镜佩戴者中有62%.
与软透镜 (700美元) 和非透镜 (500美元) 佩戴者相比,状透镜佩戴者报告了更高的每日时间承诺 (>20分钟为72%) 和年平均支出 (1500美元).
所有组都表现出严重的OSDI分数.

结论:

治疗性隐形眼镜的佩戴者,特别是状眼镜的佩戴者,经常会经历视觉障碍,如中午雾.
眼镜佩戴者将更多的时间和财力投入到干眼的管理上.
患者报告的结果强调了DED管理的重大负担,即使使用专用镜头.

更多相关视频

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

相关概念视频

Accessory Structures of the Eye

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...